Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postauricular Glucocorticoid Injection for Sudden Hearing Loss
NCT02026479Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Jan 2014
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
01
Overview
Randomised, open-label trial of dexamethasone sodium phosphate in sudden sensorineural hearing loss (SSHL) (3 arms), sponsored by Peking University People's Hospital. Primary endpoint: Pure tone audiometry test at Day 30. Status: unknown.
02
Drugs
dexamethasone sodium phosphate
03
Conditions
sudden sensorineural hearing loss (SSHL)
Beyond the preview
Go deeper on NCT02026479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02026479.